Method for preparing CAR-T cell by CRISPR/Cas9

A cell and DNA sequence technology, applied in the field of biology, to achieve the effect of high editing efficiency, avoiding potential safety hazards and high safety

Inactive Publication Date: 2015-09-09
NANJING KAEDI BIOTECH INC
View PDF1 Cites 63 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] However, CAR-T cells currently used in clinical trials in the world generally use viral vectors to int

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing CAR-T cell by CRISPR/Cas9
  • Method for preparing CAR-T cell by CRISPR/Cas9
  • Method for preparing CAR-T cell by CRISPR/Cas9

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0020] Example 1 (Preparation Example)

[0021] Use CRISRP / Cas9 system to produce leukemia CAR-T cells:

[0022] 1) T cell separation and culture

[0023] a. Separate fresh peripheral blood mononuclear cells (PBMC, peripheral blood mononuclear cell) by density gradient centrifugation;

[0024] b. Use paramagnetic beads coupled with anti-CD3 and anti-CD28 antibodies (Dynabeads ClinExVivo CD3 / CD28, Invitrogen, Camarillo, CA, USA) to enrich CD3+ cells, the ratio of magnetic beads to cells is 3:1; the cells are diluted to TNC (Total nucleated cell) concentration is 20-30x106 / mL, incubated with magnetic beads in a petri dish for 2 hours at room temperature;

[0025] c. Use Magnetic particles concentrator (MPC) (Invitrogen) to enrich CD3+ cells; cells containing CD3+ are resuspended in culture medium (OpTmizer TM CTS TM In T-Cell Expansion SFM, Life Technologies), the final concentration is 1x 106 cells / mL. Incubate for 2 days in a 37°C, 5% CO2 incubator.

[0026] 2) Construction of CRIS...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a method for preparing a CAR-T cell by CRISPR/Cas9. The method comprises integrating a CAR molecule into a first intron of a human 19th chromosome AAVS1 site by a CRISPR/Cas9 technology, and integrating antibody molecules of various tumor surface antigens into a human T cell genome AAVS1 site by CRISPR/Cas9. The method realizes accurate integration of the CAR molecule into a human T cell genome specific safe port site, does not influence human normal gene functions, and prevents a series of clinical risks such as viral vector safety hidden trouble and genetic toxicity and immunogenicity caused by insertion of an exogenous gene into a genome.

Description

technical field [0001] The invention relates to a method for preparing CAR-T cells by using CRISPR / Cas9, which belongs to the field of biology. Background technique [0002] The immune system is the defense system of the human body. On the one hand, it plays the role of removing bacteria, viruses, and foreign substances. On the other hand, it eliminates aging cells and mutated cells in the body. Some mutated cells will become cancer cells. The result of the interaction between the body's immune system and cancer cells determines the ultimate evolution of cancer. For healthy people, their immune system is strong enough to eliminate cancer cells caused by mutations in the body in time. However, for patients with cancer cells, it is common for the immune system to be low and unable to effectively identify and kill cancer cells; To escape the recognition and killing of immune cells, the immunotherapy of cancer is to improve the immunogenicity of cancer with the help of molecul...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N5/10C12Q1/02
Inventor 熊波
Owner NANJING KAEDI BIOTECH INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap